QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,386 | $447 | $390 | $851 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $100 | $0 | $343 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $319 | $64 | $73 | $96 |
| Total Curr. Assets | $1,705 | $610 | $463 | $1,290 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,705 | $610 | $463 | $1,290 |
| Liabilities | – | – | – | – |
| Payables | $570 | $1,206 | $912 | $869 |
| Short-Term Debt | $8 | $8 | $8 | $8 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$1,206 | -$912 | $0 |
| Other Curr. Liab. | $456 | $497 | $459 | $421 |
| Total Curr. Liab. | $1,033 | $1,710 | $1,378 | $1,297 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $876 |
| Other Liabilities | $0 | $0 | $0 | -$876 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,033 | $1,710 | $1,378 | $1,297 |
| Equity | – | – | – | – |
| Pref Stock | $509 | $743 | $736 | $728 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$40,159 | -$39,675 | -$38,470 | -$37,232 |
| AOCI | -$1,346 | -$418 | -$379 | -$35 |
| Other Equity | $41,667 | $38,249 | $37,198 | $36,532 |
| Total Equity | $672 | -$1,100 | -$915 | -$7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,705 | $610 | $463 | $1,290 |
| Net Debt | -$1,379 | -$439 | -$382 | -$844 |